ALS Overview - ALS Society of Canada
ALS Overview Amyotrophic lateral sclerosis (ALS), also known as Lou Gehrig’s disease, is a motor neuron disease characterized by the progressive degeneration of nerve cells in the brain and spinal …
Primary Lateral Sclerosis (PLS) is a rare progressive neurodegenerative disease which is similar to ALS. However, ALS and PLS are not the same thing. Unlike ALS, PLS only afects the upper motor …
Research Update, January 2025 - ALS Society of Canada
Jan 16, 2025 · A recent study led by Dr. Benatar et al. investigated NfL levels as a prognostic biomarker for predicting ALS progression and survival. Researchers collected several biochemical and clinical …
Inside the Science: Imaging and ALS - ALS Society of Canada
May 12, 2025 · For example, in a recent study by Dr. van Veenhuijzen et al., researchers studied brain scans of asymptomatic C9orf72 variant carriers to better understand and gain insights into when and …
What is bulbar ALS? Bulbar ALS is a subtype of ALS that destroys motor neurons in the corticobulbar area of the brain and brainstem. This area controls muscles in the face, head, and neck including the …
HOW DO THEY DIFFER? Amyotrophic lateral sclerosis, multiple sclerosis, and muscular dystrophy can sometimes be confused as the characteristics and symptoms of these diseases can overlap. People …
Who We Are - ALS Society of Canada
Who We Are We work together as a community of truth speakers, rabble-rousers, uplifters, and progress-makers to change what it means to live with ALS in Canada.
Can the key to slowing ALS progression be found in the immune cells …
May 15, 2019 · We are relentlessly working to change the reality for people living with ALS, through support, advocacy and investment in research.
to children about ALS When a family member is diagnosed with amyotrophic lateral sclerosis (ALS), children may notice changes and have questions. Shielding them from the truth can be more harmful …
Home - ALS Canada
We are relentlessly working to change the reality for people living with ALS, through support, advocacy and investment in research.